NL
PDLI

NWAM LLC’s PDL BioPharma, Inc. PDLI Stock Holding History

NWAM LLC’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,642
Closed -$87K – 308
2014
Q3 		$87K Buy
+11,642
New +$108K 0.03% 284
2014
Q2 		– Sell
-10,465
Closed -$87K – 310
2014
Q1 		$87K Buy
+10,465
New +$89.7K 0.03% 258
2013
Q4 		– Sell
-11,612
Closed -$93K – 222
2013
Q3 		$93K Sell
11,612
-376
-3% -$3.02K 0.05% 196
2013
Q2 		$93K Buy
+11,988
New +$93.5K 0.05% 196

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NWAM LLC's PDLI Position: Q4 2014 in Review

NWAM LLC sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 11,642 shares — an estimated $87K sold.

NWAM LLC first reported a position in PDLI in Q2 2013 and held it in 4 quarters. The position peaked at $93K in Q3 2013. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

  • NWAM LLC reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
  • NWAM LLC sold 11,642 PDL BioPharma, Inc. shares in Q4 2014, an estimated $87K.
  • NWAM LLC first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 4 quarters.
  • NWAM LLC's PDL BioPharma, Inc. position peaked at $93K in Q3 2013.
  • 223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on NWAM LLC's 13F filing for Q4 2014, filed 9 Sep 2016.